Why Did Moderna Stock Rise 12%?

09:02am, Wednesday, 08'th Jan 2025
The stock price of Moderna saw a 12% jump on Tuesday, January 7, amid rising cases of Covid-19 and flu in the U.S. Along with Moderna, stocks of other vaccine makers also saw an uptick. Novavax was up
Introduction of a Universal Coronavirus Vaccine : A robust cross-immunity effect to combat virus mutations. SEOUL, South Korea , Jan. 8, 2025 /PRNewswire/ -- The COVID-19 pandemic has fundamentally tr

Here's why vaccine stocks are surging in 2025

08:31am, Wednesday, 08'th Jan 2025
After undergoing years of stock market decline as reporting and awareness about the COVID-19 pandemic subsided, major vaccine stocks received a major, if grim, boost in early 2025.
The first bird-flu fatality in the United States sparks investor interest in several vaccine makers that are developing experimental H5N1 vaccines.
Moderna (MRNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
It might seem that valuation is no longer important for investors. Stocks that have sky-high valuation metrics continue to soar.
Moderna (MRNA) shares soared Tuesday as investors placed bets that the pharmaceutical giant's development of an H5N1 bird flu vaccine could boost sales after the first death linked to the disease was

Is The Moderna Stock (MRNA) Rally For Real?

05:29pm, Tuesday, 07'th Jan 2025
Without our health
Major U.S. equities indexes lost ground as the latest Purchasing Managers' Index (PMI) showed an expansion in the manufacturing sector but revealed an increase in the "prices paid" index during Decemb
Moderna (MRNA) shares jumped more than 10% to lead S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S. The biotech company is developing a vaccine for H5N1.
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares surged alongside rival vaccine makers on Tuesday after news broke of the first human death related to the H5 bird flu strain in the US. America's Centers for
The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through North America.
In the latest trading session, Moderna (MRNA) closed at $42.18, marking a +0.43% move from the previous day.
Moderna's partnership with Merck in personalized cancer therapies and promising Phase III trials support a speculative 'Buy' for long-term investors with high-risk tolerance. Despite a tough 2024, MRN
Of the 503 stocks in the S&P 500 (some companies have two classes of stocks that are included) fewer than 30% of them, or 148 stocks, beat the index's average return of 23.31% in 2024.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE